Emerging studies suggest that the dysregulation of SCAMP1 is related to the occurrence and progression of various tumors, including pancreatic cancer, gallbladder cancer, cervical cancer and breast cancer [10–12]. This evidence concerns the gene SCAMP1 and pancreatic neoplasm.